SIG
PHAS

Sargent Investment Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Sargent Investment Group’s Portfolio PHAS Stock Details PHAS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,675
Closed -$30K – 201
2021
Q4 		$30K Buy
+11,675
New +$30K 0.01% 182